ARCHIVES

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: Judith Salerno Named President and CEO of Komen

June 21, 2013

NCI RFP Available.

February 11, 2000

NCAB Subcommittee Likes Organ Site Program, Except Smoking-Health

April 30, 1976

Heckler Announces NCI Team Headed By Gallo Has Found Cause Of AIDS

April 27, 1984

FDA Approves Treatment For Late-Stage Cervical Cancer

June 30, 2006

Rosenberg’s Adoptive Immunotherapy Update

December 6, 1985